- Home
- SEDG vs CPRX Comparison
SEDG vs CPRX Comparison
Compare SEDG & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SEDG | CPRX |
|---|---|---|
| Founded | 2006 | 2002 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.9B |
| IPO Year | 2015 | 2006 |
Fundamental Metrics
Financial Performance| Metric | SEDG | CPRX |
|---|---|---|
| Price | $53.15 | $31.49 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 20 | 1 |
| Target Price | $30.97 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 2.4M | 2.0M |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 78.26 | 28.24 |
| EPS | N/A | ★ 0.50 |
| Revenue | ★ $1,184,444,000.00 | $119,072,803.00 |
| Revenue This Year | $19.97 | $9.20 |
| Revenue Next Year | $13.79 | $10.51 |
| P/E Ratio | ★ N/A | $62.98 |
| Revenue Growth | ★ 31.39 | 16.39 |
| 52 Week Low | $23.01 | $19.05 |
| 52 Week High | $81.25 | $32.56 |
Technical Indicators
Market Signals| Indicator | SEDG | CPRX |
|---|---|---|
| Relative Strength Index (RSI) | 47.15 | 70.31 |
| Support Level | $31.88 | $31.25 |
| Resistance Level | $60.94 | $32.56 |
| Average True Range (ATR) | 4.64 | 0.04 |
| MACD | -0.03 | -0.05 |
| Stochastic Oscillator | 43.37 | 86.96 |
Price Performance
Historical ComparisonAbout SEDG SolarEdge Technologies Inc.
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.